OraSure Technologies | OSUR - Sales Revenues


OraSure Technologies reported $26.76M in Sales Revenues for its fiscal quarter ending in December of 2025.





Sales Change Date
Agilent USD 1.84B 37M Mar/2026
AngioDynamics USD 79.43M 3.72M Sep/2025
Becton, Dickinson and Co. USD 5B 300M Jun/2026
Bio Techne USD 321.2M 9.8M Jun/2026
Bio-Rad Laboratories USD 651M 58.9M Jun/2026
Bruker USD 838.5M 15.1M Jun/2026
Cerus USD 50.81M 4.79M Dec/2024
Charles River Laboratories USD 1000M 4.2M Jun/2026
Danaher USD 6.3B 350M Jun/2026
Dentsply International USD 898M 18M Jun/2026
Dexcom USD 1.31B 120M Jun/2026
Illumina USD 1.16B 70M Jun/2026
Integra LifeSciences USD 418.8M 26.9M Jun/2026
Intuitive Surgical USD 2.89B 120M Jun/2026
IQVIA Holdings USD 4.37B 220M Jun/2026
Mesa Laboratories USD 62.84M 5.01M Dec/2024
Mettler Toledo International USD 1.03B 82.87M Jun/2026
Myriad Genetics USD 190.7M 9.7M Jun/2026
OraSure Technologies USD 26.76M 322K Dec/2025
Quidel USD 630.9M 10.9M Jun/2026
Repligen USD 204M 10M Jun/2026
Revvity USD 729.68M 18.68M Jun/2026
STAAR Surgical USD 93.5M 0 Jun/2026
Thermo Fisher Scientific USD 11.99B 980M Jun/2026
Trinity Biotech USD 11.07M 3.24M Dec/2025
Waters USD 1.64B 370M Jun/2026